RxDoctor Payments Data

Josie Eoff

Nurse Practitioner · Sullivan, MONPI 1659857415

Payments from drug & device makers

$2,758in general payments, 2019–2025

Across 160 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$609
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$539
  • Gilead$457
  • Johnson & Johnson$262
  • Pfizer$182
  • Intercept Pharmaceuticals, Inc.$105
  • plus $604 from 15 others

What the payments were for

  • Food & beverage$2,60594%
  • Education$1536%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,758 in reported general payments places this provider in the 85th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$21,074
Medicare patients
189
Services billed
301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin47$155,375
CreonLipase/Protease/Amylase47$125,092
RezdiffraResmetirom17$115,745
RelistorMethylnaltrexone Bromide14$53,956
LinzessLinaclotide57$43,559
IbsrelaTenapanor Hcl12$22,147
Mesalamine12$8,299
Budesonide DrBudesonide35$8,215
Dexlansoprazole DrDexlansoprazole37$7,571
MovantikNaloxegol Oxalate11$6,904
Epinephrine29$6,097
Lubiprostone30$3,308
Famotidine150$2,622
Pantoprazole Sodium232$2,419
Dicyclomine Hcl104$1,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Relistor$539$209,33161 claims
AbbVieCreon, Linzess$609$168,651104 claims
Madrigal PharmaceuticalsRezdiffra$39$115,74517 claims
Redhill Biopharma Inc.Movantik$97$6,90411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Sullivan

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →